BioVie Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
BioVie Inc. (BIVI) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 10.69 million shares for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- BioVie Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 8.40M shares, a 1612.21% increase year-over-year.
- BioVie Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-09-30 was 490.44K shares, a 62.27% decline year-over-year.
- BioVie Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-09-30 was 1.30M shares, a 88.45% decline year-over-year.
- BioVie Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-09-30 was 11.25M shares, a 409.91% increase year-over-year.
- BioVie Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2026 was 10.69M shares, a 915.76% increase from fiscal 2025.
- BioVie Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 1.05M shares.
- BioVie Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 1.30M shares, a 67.68% decline from fiscal 2022.
- BioVie Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 4.03M shares, a 341.34% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 10.69M shares 10-K · filed 2026-08-13 | |||||||
| 2026-03-31 | 10.69M shares S-1/A · filed 2026-08-06 | |||||||
| 2025-12-31 | 7.98M shares 10-Q · filed 2026-02-06 | |||||||
| 2025-09-30 | 8.40M shares 10-Q · filed 2025-11-10 | |||||||
| 2025-06-30 | 1.05M shares 10-K · filed 2026-08-13 | 1.05M shares 10-K · filed 2025-08-15 | ||||||
| 2025-03-31 | 1.06M shares S-1/A · filed 2026-08-06 | 10.60M shares 10-Q · filed 2025-05-12 | ||||||
| 2024-12-31 | 1.07M shares 10-Q · filed 2026-02-06 | 10.67M shares 10-Q · filed 2025-02-11 | ||||||
| 2024-09-30 | 490.44K shares 10-Q · filed 2025-11-10 | 4.90M shares 10-Q · filed 2024-11-13 | ||||||
| 2024-06-30 | 256.20K shares S-1/A · filed 2026-08-06 | 2.56M shares 10-K · filed 2024-09-30 | ||||||
| 2024-03-31 | 2.46M shares 10-Q · filed 2025-05-12 | 23.88M shares 10-Q · filed 2024-05-14 | ||||||
| 2023-12-31 | 1.39M shares 10-Q · filed 2025-02-11 | 12.63M shares 10-Q · filed 2024-02-13 | ||||||
| 2023-09-30 | 1.30M shares 10-Q · filed 2024-11-13 | 12.28M shares 10-Q · filed 2023-11-08 | ||||||
| 2023-06-30 | 1.30M shares 10-K · filed 2024-09-30 | 12.32M shares 10-K · filed 2023-08-16 | ||||||
| 2023-03-31 | 11.75M shares 10-Q · filed 2024-05-14 | 11.74M shares 10-Q · filed 2023-05-12 | ||||||
| 2022-12-31 | 11.88M shares 10-Q · filed 2024-02-13 | 11.22M shares 10-Q · filed 2023-02-10 | ||||||
| 2022-09-30 | 11.25M shares 10-Q · filed 2023-11-08 | 11.13M shares 10-Q · filed 2022-11-04 | ||||||
| 2022-06-30 | 4.03M shares 10-K · filed 2023-08-16 | 3.91M shares 10-K · filed 2022-09-27 | ||||||
| 2022-03-31 | 2.95M shares 10-Q · filed 2023-05-12 | |||||||
| 2021-12-31 | 2.57M shares 10-Q · filed 2023-02-10 | |||||||
| 2021-09-30 | 2.21M shares 10-Q · filed 2022-11-04 | |||||||
| 2021-06-30 | 913.96K shares 10-K · filed 2022-09-27 | |||||||
| 2021-03-31 | 928.22K shares 10-Q · filed 2022-05-11 | |||||||
| 2020-12-31 | 965.07K shares 10-Q · filed 2022-02-08 | |||||||
| 2020-09-30 | 271.87K shares 10-Q · filed 2021-11-10 | |||||||
| 2020-06-30 | 1.44M shares 10-K · filed 2021-08-30 | |||||||
| 2020-03-31 | 1.44M shares 10-Q · filed 2020-05-13 | |||||||
| 2019-12-31 | 1.44M shares 10-Q · filed 2020-02-13 | |||||||
| 2019-09-30 | 1.37M shares 10-Q · filed 2020-11-05 | 179.08M shares 10-Q · filed 2019-11-19 | ||||||
| 2019-06-30 | 182.67K shares 10-K/A · filed 2020-08-07 | 22.83M shares 10-K · filed 2019-09-27 | ||||||
| 2019-03-31 | 1.79M shares 10-Q · filed 2020-05-13 | 223.69M shares 10-Q · filed 2019-05-10 | ||||||
| 2018-12-31 | 1.78M shares 10-Q · filed 2020-02-13 | 221.99M shares 10-Q · filed 2019-02-12 | ||||||
| 2018-09-30 | 221.59M shares 10-Q · filed 2019-11-19 | 221.59M shares 10-Q · filed 2018-11-14 | ||||||
| 2018-06-30 | 9.92M shares 10-Q · filed 2018-11-14 | 9.92M shares 10-K · filed 2019-09-27 | 10.17M shares 10-K · filed 2018-10-05 | |||||
| 2017-06-30 | 9.92M shares 10-K · filed 2018-10-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |